News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bodmer Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 3,128 shares
@ $9.51, valued at
$29.7k
Exercised 6,625 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 22,571 shares
@ $0.1418, valued at
$3.2k
|
|
| 05/10/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 68,014 shares
@ $0.1255, valued at
$8.5k
|
|
| 05/09/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 132,500 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 530,000 restricted stock units
@ $0 |
|
| 01/21/2022 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 125,000 options to buy
@ $5.05, valued at
$631.3k
|
|
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2020 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 100,000 options to buy
@ $7.06, valued at
$706k
|
|
| 01/16/2019 |
4
| Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 100,000 options to buy
@ $13.71, valued at
$1.4M
|
|
| 05/10/2018 |
4
| Bodmer Mark (See Remarks) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 55,437 options
@ $16, valued at
$887k
|
|
|
|